Recombinant collagen hemorrhoid wound repair evaluation method
By establishing unified assessment rules and data collection standards, the problem of inconsistent evaluation dimensions in the assessment of recombinant collagen hemorrhoid wound repair was solved, achieving consistency and comparability of assessments across individuals and institutions, and improving the scientific nature and credibility of the assessment.
Patent Information
- Application Number
- CN202610361117.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2026-03-23
- Publication Date
- 2026-06-23
AI Technical Summary
In existing technologies, the evaluation of the effect of recombinant collagen on hemorrhoid wound repair lacks unified evaluation rules and quantitative grading, resulting in inconsistent evaluation dimensions, strong subjectivity, poor comparability of results across individuals and institutions, and failure to meet the needs of clinical evaluation and R&D optimization.
By setting unified assessment rules and data collection standards, including observation time points, assessment dimensions, quantitative grading criteria, and comprehensive judgment thresholds, and combining standardized collection of wound imaging and symptom scales, we can achieve consistency and comparability of assessments across individuals and institutions.
This study standardizes the assessment of recombinant collagen for hemorrhoid wound repair, ensuring the consistency and reliability of assessment results. It provides a comprehensive judgment based on both objective and subjective dimensions, supports cross-individual and cross-institutional result review and comparison, and enhances the scientific rigor and credibility of the assessment.